Yokohama, Japan

Takako Fujimoto

This inventor holds 4 USPTO granted patents. Top assignee: Eisai Company, Limited. Active years: 1981-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takako Fujimoto. Retrieved from https://idiyas.com/inventor/takako-fujimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 1981-1986

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Takako Fujimoto: Innovator in Anti-Depressant Compounds

Introduction

Takako Fujimoto is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-depressant compounds. With a total of 4 patents to her name, her work has the potential to impact the treatment of depression and related conditions.

Latest Patents

Fujimoto's latest patents include innovative anti-depressant imidazoles. These compounds are characterized by their unique chemical structures, which allow them to function effectively as agents for treating depression and depressive states. The specific formulations involve various substituents that enhance their therapeutic properties, making them valuable in the pharmaceutical industry.

Career Highlights

Throughout her career, Takako Fujimoto has been associated with Eisai Company, Limited, a leading pharmaceutical company. Her work has focused on creating compounds that address mental health issues, showcasing her dedication to improving patient outcomes through innovative solutions.

Collaborations

Fujimoto has collaborated with notable colleagues in her field, including Motosuke Yamanaka and Isao Saito. These partnerships have contributed to her success and the advancement of her research in anti-depressant compounds.

Conclusion

Takako Fujimoto's contributions to the field of pharmaceuticals, particularly in the development of anti-depressant compounds, highlight her role as an influential inventor. Her work continues to pave the way for advancements in mental health treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…